Wemade integreert Fireblocks, de toonaangevende leverancier van technologie voor digitale activa
Reading Time: 2 minutesFireblocks versterkt met veilige, hoogwaardige infrastructuurtechnologie het vermogensbeheer van WEMIX Vereist voor de meeste wereldwijde partnerschappen, een noodzakelijke stap naar meer robuuste, wereldwijde business voor WEMIX SEOUL, Zuid-Korea, 3 juni 2023 /PRNewswire/ — De wereldwijd toonaangevende blockchainontwikkelaar Wemade heeft vandaag de integratie bekendgemaakt van Fireblocks, de toonaangevende aanbieder van bewaar-, overdrachts- en settlementtechnologie voor digitale […]
Wemade intègre Fireblocks, le fournisseur de technologie d’actifs numériques leader de l’industrie
Reading Time: 3 minutesLa gestion des actifs WEMIX sera renforcée grâce à la technologie d’infrastructure sécurisée de qualité entreprise de Fireblocks Obligatoire pour la plupart des partenariats mondiaux, il s’agit d’une étape nécessaire vers une activité mondiale plus robuste pour WEMIX SÉOUL, Corée du Sud, 3 juin 2023 /PRNewswire/ — Le développeur de blockchain de premier plan Wemade […]
La ville de Sanmenxia en Chine centrale insuffle une nouvelle vitalité et favorise un développement de qualité grâce à des événements culturels
Reading Time: 2 minutesPÉKIN, 3 juin 2023 /PRNewswire/ — La ville de Sanmenxia, dans la province du Henan, en Chine centrale, a mis en œuvre 78 projets pour un investissement total de 92,76 milliards de yuans (environ 13,07 milliards de dollars américains) lors du 28e festival de tourisme culturel du fleuve Jaune de Sanmenxia. Le festival a débuté le 19 mai à Sanmenxia, […]
Janssen Presents Longer-Term Talquetamab Follow-Up Data Showing Overall Response Rates of More Than 70 Percent in Heavily Pretreated Patients with Multiple Myeloma
Reading Time: 15 minutesAdditional long-term data from the TRiMM-2 study in patients receiving talquetamab and DARZALEX FASPRO® combination biweekly regimen showed an overall response rate of more than 80 percent CHICAGO, June 3, 2023 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson announced today updated results from the pivotal Phase 1/2 MonumenTAL-1 study of the investigational […]
ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages Bowlero Corp. Investors to Inquire About Securities Class Action Investigation
Reading Time: 2 minutesNEW YORK, June 3, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Bowlero Corp. (NYSE: BOWL) resulting from allegations that Bowlero may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Bowlero securities […]
Luminar Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Reading Time: 3 minutesSAN DIEGO, June 3, 2023 /PRNewswire/ — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Luminar Technologies, Inc. (NASDAQ: LAZR) securities between February 28, 2023 and March 17, 2023, both dates inclusive (the “Class Period”) have until July 25, 2023 to seek appointment as lead plaintiff of […]
Funko, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Reading Time: 3 minutesSAN DIEGO, June 3, 2023 /PRNewswire/ — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Funko, Inc. (NASDAQ: FNKO) common stock on a U.S. open market between May 6, 2022 and March 1, 2023, inclusive (the “Class Period”) have until August 1, 2023 to seek appointment as […]
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Microvast Holdings, Inc. Investors to Inquire About Securities Class Action Investigation
Reading Time: 2 minutesNEW YORK, June 3, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Microvast Holdings, Inc. (NASDAQ: MVST, MVSTW) resulting from allegations that Microvast may have issued materially misleading business information to the investing public. SO WHAT: If you purchased […]
Janssen Presents First-Ever Results from Dual Bispecific Combination Study Showing 96 Percent Overall Response Rate in Patients with Relapsed or Refractory Multiple Myeloma
Reading Time: 11 minutesCHICAGO, June 3, 2023 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the first-ever results from the Phase 1b RedirecTT-1 study of TECVAYLI® (teclistamab-cqyv), a first-in-class BCMAxCD3 bispecific antibody, and talquetamab, a first-in-class GPRC5DxCD3 bispecific antibody, showing a high overall response rate (ORR) among patients with relapsed or refractory multiple myeloma (RRMM).1 […]
NextEra Energy, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Reading Time: 4 minutesSAN DIEGO, June 3, 2023 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP purchasers or acquirers of NextEra Energy, Inc. (NYSE: NEE) securities between December 2, 2021 and February 1, 2023, both dates inclusive (the “Class Period”) have until July 25, 2023 to seek appointment as lead plaintiff of the NextEra Energy class action lawsuit. […]